GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello AS (CHIX:ALKBc) » Definitions » Accounts Payable

Alk-Abello AS (CHIX:ALKBC) Accounts Payable : kr165 Mil (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Alk-Abello AS Accounts Payable?

Alk-Abello AS's Accounts Payable for the quarter that ended in Dec. 2024 was kr165 Mil.

Alk-Abello AS's quarterly Accounts Payable declined from Jun. 2024 (kr189 Mil) to Sep. 2024 (kr118 Mil) but then increased from Sep. 2024 (kr118 Mil) to Dec. 2024 (kr165 Mil).

Alk-Abello AS's annual Accounts Payable declined from Dec. 2022 (kr131 Mil) to Dec. 2023 (kr128 Mil) but then increased from Dec. 2023 (kr128 Mil) to Dec. 2024 (kr165 Mil).

Alk-Abello AS Accounts Payable Historical Data

The historical data trend for Alk-Abello AS's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alk-Abello AS Accounts Payable Chart

Alk-Abello AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 74.00 115.00 131.00 128.00 165.00

Alk-Abello AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 128.00 134.00 189.00 118.00 165.00

Alk-Abello AS Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Alk-Abello AS Accounts Payable Related Terms

Thank you for viewing the detailed overview of Alk-Abello AS's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Alk-Abello AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello AS (CHIX:ALKBc) » Definitions » Accounts Payable
Comparable Companies
OCSE:ZEAL OCSE:BAVA OCSE:GUBRA OCSE:PEG OCSE:STRAP OCSE:GMAB VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270 SMMT RPRX XKRX:196170 INSM
Traded in Other Exchanges
0OIR:UK ALK B:Denmark 4AJ0:Germany
Address
Boge Alle 6-8, Horsholm, DNK, DK-2970
Website
https://www.alk.net
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.

Alk-Abello AS Headlines

No Headlines